Geoff Banks, Ph.D.
President & CEO, Clinical Pharmacology Consultant

Geoffrey Banks, Ph.D. is President, CEO, and founder of ClinPharm Consulting and an experienced clinical pharmacology consultant. Dr. Banks has over 10 years of experience in large pharma, biotechnology, and specialty pharma with an established track record of clinical, regulatory and entrepreneurial success within the pharmaceutical industry. Dr. Banks has extensive experience in planning, executing, and analyzing Phase 1 studies as well as cross-functional experience in strategic planning and execution of entire drug development programs (from nonclinical IND enabling studies through Phase 1 to late stage studies leading to marketing registration). Having founded ClinPharm Consulting in mid-2008, Dr. Banks has grown the company from an individual consultancy to a leading clinical pharmacology consulting firm with an expanding clientele and employee roster through an inherent focus on quality and cost-effective consulting services.

M. Alexander Shaw, Ph.D.
Chief Operating Officer, Clinical Pharmacology Consultant

M. Alexander Shaw, Ph.D. has been involved in basic, applied, and clinical research, with a focus on research with biologics, throughout his 15-year career. Dr. Shaw performed his undergraduate work at Duke University, receiving B.S. degrees in Chemistry and Biology, followed by graduate work at Washington State University. He continued his training as an American Heart Association Post-doctoral fellow at the University of Pennsylvania. His 6 years directing bioanalytical laboratories as a faculty member at Thomas Jefferson University and as the National Applications Laboratory Manager at Hitachi High Technologies America highlight his scientific expertise. Dr. Shaw is also an accomplished scientific and medical writer, having contributed to wide variety of regulatory, scientific, clinical pharmacology, and commercial documents for industry and academia.

Bill Wargin, Ph.D.
Executive Vice President, Pharmacokinetics
Chief Scientific Officer

Bill Wargin received a Ph.D. in Pharmacokinetics from the University of Minnesota in 1978 and began his career as an Assistant Professor at the University of North Carolina School of Pharmacy as an instructor in clinical pharmacokinetics. Dr. Wargin transitioned to industry in 1983 at Burroughs Wellcome (later Glaxo Wellcome) where he held senior leadership positions in pharmacokinetics and pharmaceutical project management until 2001. Positions held at Burroughs Wellcome and Glaxo Wellcome included International Director of Clinical Pharmacology for Oncology, Anti-emesis & Anesthesiology and US Site Director, R&D Worldwide Project Planning. Since 2001, he has successfully consulted as a pharmacokineticist focused on early phase pharmaceutical research and development. Dr. Wargin has worked with over 80 clients in the pharmaceutical and biotechnology industry and was an expert reviewer for the Biopharmaceutics Branch of the FDA. He is an author or co-author of over 30 journal articles in pharmacokinetics/biopharmaceutics.

Steve Grossman, M.D.
Senior Medical and Clinical Research Consultant

Steven Grossman, MD is board certified in Internal Medicine and Nephrology and has the Specialist designation from the American Society of Hypertension. He is a Clinical Associate Professor of Medicine at the University of North Carolina School of Medicine in Chapel Hill, NC where he serves as an attending physician in the Hypertension Clinic and on the Nephrology Consult Service. He served in a wide variety of roles in clinical research at Burroughs Wellcome, Glaxo Wellcome and GlaxoSmithKline for over 18 years primarily in cardiovascular and critical care drug development. He was senior Medical Director at Lineberry Research Associates/Constella Group for over 5 years before becoming an independent consultant.

Dr. Grossman received a Bachelor’s degree in chemistry from the University of North Carolina at Chapel Hill in 1969 and his medical degree from the Medical College of Virginia in 1973. Upon completion of a residency in Internal Medicine at MCV, he completed a Nephrology Fellowship at Duke University Medical Center with additional post-graduate work in clinical pharmacology.